431 related articles for article (PubMed ID: 17664481)
21. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of follicular lymphomas.
Luminari S; Federico M
Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
[TBL] [Abstract][Full Text] [Related]
23. Interferon alfa for the treatment of follicular lymphomas.
Hiddemann W; Griesinger F; Unterhalt M
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma.
Troch M; Wöhrer S; Raderer M
Anticancer Res; 2010 Feb; 30(2):635-9. PubMed ID: 20332482
[TBL] [Abstract][Full Text] [Related]
25. Primary follicular lymphoma of the gastrointestinal tract.
Misdraji J; Harris NL; Hasserjian RP; Lauwers GY; Ferry JA
Am J Surg Pathol; 2011 Sep; 35(9):1255-63. PubMed ID: 21836483
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
27. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396
[TBL] [Abstract][Full Text] [Related]
29. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
[TBL] [Abstract][Full Text] [Related]
31. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
32. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
Møller MB; Pedersen NT; Christensen BE
Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in follicular lymphoma.
Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
[TBL] [Abstract][Full Text] [Related]
35. A single unit lymphoma experience: outcome in a Cape Town academic centre.
Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
[TBL] [Abstract][Full Text] [Related]
37. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
Krishnan A; Nademanee A; Fung H; Angelopoulou M; Molina A; Gaal K; Dagis A; Palmer J; Alvarnas J; Slovak M; Kogut N; Popplewell L; Rodriguez R; Schriber J; Wang S; Forman SJ
Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937
[TBL] [Abstract][Full Text] [Related]
38. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
40. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.
Alvaro T; Lejeune M; Camacho FI; Salvadó MT; Sánchez L; García JF; Lopez C; Jaén J; Bosch R; Pons LE; Bellas C; Piris MA
Haematologica; 2006 Dec; 91(12):1605-12. PubMed ID: 17145596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
